Summary: DermaSensor is an FDA-cleared, handheld device designed to help clinicians assess the risk of skin cancer in suspicious skin lesions. It uses a combination of optical spectroscopy and artificial intelligence to analyze lesions and provide immediate risk assessment results. This tool aims to enhance clinical confidence, support timely referrals, and improve patient outcomes by offering an objective, non-invasive method for skin cancer evaluation.

Summary: Triage utilizes artificial intelligence to analyze photos of skin problems, providing users with an instant differential diagnosis of potential skin conditions. Created by a team of doctors and scientists, this tool aims to simplify the process of understanding skin issues by offering a quick and accurate analysis. It integrates privacy and user-friendliness, making dermatological advice more accessible.

Summary: MAGENTIQ-COLO™ leverages artificial intelligence and machine learning to assist gastroenterologists in detecting polyps during colonoscopies, aiming to increase adenoma detection rates and reduce the miss rate of sessile serrated adenomas. With over 65 million frames processed and validated by a comprehensive study, the tool integrates into gastroenterology clinics to support clinical decision-making and improve the quality of colonoscopy procedures.

Summary: Eko AI leverages FDA-cleared artificial intelligence to augment the capabilities of digital stethoscopes, enabling clinicians to detect heart and lung diseases more accurately. It offers enhanced audio quality, active noise cancellation, real-time visualizations of heart sounds and ECG tracings, and automatic record-keeping for patient exams. This technology aims to improve patient care by supporting early and precise disease detection.

Summary: The Sepsis ImmunoScore is a groundbreaking diagnostic tool that leverages artificial intelligence to diagnose sepsis and predict patient outcomes. By integrating biomarkers with clinical data, it provides critical information in real-time, enabling healthcare providers to deliver optimal therapy swiftly. Its direct integration into hospital Electronic Health Records (EHRs) facilitates timely interventions, thereby improving patient outcomes, enhancing hospital quality metrics, and reducing costs.

Summary: SKOUT by Iterative Health is designed to assist physicians during colorectal cancer screening and surveillance by providing real-time AI analysis. This tool aims to enhance the accuracy and efficiency of screenings, helping in the early detection and monitoring of colorectal cancer. By integrating advanced AI algorithms, SKOUT serves as an additional layer of analysis to support healthcare professionals in making more informed decisions.

Summary: Buoy Health utilizes artificial intelligence to provide users with personalized health assessments based on their symptoms. By asking a series of questions, the tool narrows down possible conditions and suggests next steps for care. This approach aims to make health information more accessible and actionable, guiding users to the right medical advice, services, or products.

Summary: WRDensity leverages artificial intelligence to provide a more consistent assessment of breast density during mammography screenings. It is designed to integrate seamlessly with RIS/PACS systems and has been trained on over 600,000 images from the Mallinckrodt Institute of Radiology. This tool aims to create uniformity in density assessment at the practice level, improving the accuracy of breast cancer screenings.

Summary: TeraRecon provides an advanced visualization and artificial intelligence (AI) platform designed to enhance medical imaging workflows. The platform integrates with existing systems to offer AI-driven insights and decision support across various specialties including radiology, cardiology, and neurology. It aims to improve patient care by accelerating time-to-treatment and enhancing diagnostic accuracy through the use of cutting-edge AI technologies.

Summary: Koios DS™ leverages artificial intelligence and machine learning to provide clinical decision support for the diagnosis of breast and thyroid cancer through ultrasound imaging. This software aims to improve diagnostic accuracy and efficiency, potentially leading to earlier detection and treatment. With FDA clearance and CE marking, Koios DS™ integrates into clinical workflows, offering a billable procedure that enhances both survival rates and workflow efficiency.

Summary: ECG-AI™ LEF by Anumana utilizes advanced AI algorithms to analyze electrocardiogram (ECG) data for the early detection of cardiovascular diseases, including low ejection fraction, which is indicative of heart failure. This tool is designed to aid physicians in identifying at-risk patients earlier, enabling timely intervention and potentially improving patient outcomes. Anumana's technology is built on a foundation of extensive electrophysiological data and validated through clinical research.

Summary: MAUI Imaging introduces an advanced ultrasound solution capable of imaging through obstacles such as bone, air, and metal, specifically designed for the brain. This FDA-cleared technology aims to revolutionize medical imaging by providing clear, real-time visuals for diagnosing and monitoring traumatic injuries, especially in environments where traditional imaging tools like CT scans are unavailable.

Summary: UltraSight offers AI-driven software that provides real-time guidance and quality assessment for healthcare professionals performing cardiac ultrasound. Designed to assist users regardless of their sonography proficiency, the tool enables the consistent performance of high-quality cardiac ultrasound across various settings, including clinics, community hospitals, and remote areas. This innovation aims to improve the accessibility, ease, and quality of cardiac imaging and diagnosis, facilitating more accurate and timely clinical decisions.

Summary: Hermia by Hermes Medical Solutions is a comprehensive, vendor-neutral software suite designed for nuclear medicine and molecular imaging. It integrates with all equipment and staff within a medical facility, aiming to optimize the potential of nuclear medicine departments. The software supports a wide range of clinical specialties, including advanced dosimetry tools, and offers scalability to meet future clinical needs.

Summary: QuPath offers tools for visualizing and analyzing complex biological images, such as whole slide images in pathology. It supports a wide range of image types and provides features for annotation, measurement, and automated analysis to facilitate research in bioimaging. Users can customize and extend its capabilities through scripting and plugins, making it adaptable to various research needs.

Summary: DERM (Deep Ensemble for the Recognition of Malignancy) is a Class III CE marked AI as a Medical Device (AIaMD) designed to improve skin cancer triage. It integrates with teledermatology platforms to accurately triage patients with non-cancerous lesions away from cancer pathways, optimizing dermatologist capacity for the most needed cases. This technology aims to enhance patient outcomes by ensuring timely and accurate skin cancer care.

Summary: DEEPVESSEL FFR utilizes AI to perform non-invasive CT fractional flow reserve analysis, providing a physiological functional assessment of coronary arteries from coronary CT angiograms. This tool aims to minimize the need for invasive testing, enhance patient safety, and reduce the costs associated with cardiovascular care. It integrates seamlessly into clinical workflows, offering precise and comprehensive analysis to support decision-making in the management of coronary artery disease.

Summary: DovaVision offers an AI-driven solution for assessing disease severity in Ulcerative Colitis (UC) through endoscopic analysis. This tool leverages deep data analysis to provide clinicians and researchers with actionable insights, aiming to improve the accuracy of UC severity assessments. Currently available for research and clinical trials, DovaVision integrates into clinical workflows to support informed decision-making.

Summary: Ultrarad AI provides a suite of AI-powered diagnostic tools designed to improve the accuracy and efficiency of radiology interpretations. The platform includes features like Doppler Interpretations, Calculators, and TAARA, an intelligent radiology assistant, which together support a wide range of radiological examinations and workflows. These tools aim to save time for radiologists and improve patient outcomes by enabling more precise and faster diagnoses.

Summary: AssureMDx is a urine-based test designed to help physicians identify patients with hematuria who are at increased risk for bladder cancer, facilitating timely referral to urology for further clinical evaluation. The test evaluates genomic changes associated with bladder cancer, including DNA methylation status and somatic mutation status of specific genes, to stratify patients by risk and potentially avoid unnecessary invasive procedures for those at low risk.